Matthew Doctor Regis Corp (RGS) insider trading activity

RGS Quotes by TradingView

Matthew Doctor is President and CEO of REGIS CORP. Currently has a direct ownership of 76,671 shares of RGS, which is worth approximately $1.8 Million. The most recent transaction as insider was on Feb 08, 2024, when has been sold 211 shares (Common Stock) at a price of $12.35 per share, resulting in proceeds of $2,605. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.7K
0% 3M change
4.79% 12M change
Total Value Held $1.8 Million

Matthew Doctor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2024
SELL
Payment of exercise price or tax liability
$2,605 $12.35 p/Share
211 Reduced 0.27%
76,671 Common Stock
Nov 06 2023
SELL
Payment of exercise price or tax liability
$1,933 $0.53 p/Share
3,648 Reduced 4.53%
76,882 Common Stock
Nov 07 2022
SELL
Payment of exercise price or tax liability
$3,574 $1.26 p/Share
2,837 Reduced 3.4%
80,530 Common Stock
Feb 08 2022
SELL
Payment of exercise price or tax liability
$7,166 $1.65 p/Share
4,343 Reduced 4.95%
83,367 Common Stock
Nov 05 2021
BUY
Grant, award, or other acquisition
$64,849 $1.38 p/Share
46,992 Added 38.17%
76,124 Common Stock
Feb 08 2021
BUY
Grant, award, or other acquisition
-
28,382 Added 49.35%
29,132 Common Stock
MD

Matthew Doctor

President and CEO
Minneapolis, MN

Track Institutional and Insider Activities on RGS

Follow REGIS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGS shares.

Notify only if

Insider Trading

Get notified when an Regis Corp insider buys or sells RGS shares.

Notify only if

News

Receive news related to REGIS CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGS